Catalyst Wire Dossier Catalyst Wire Dossier
FDA label_change · 2015-08-06

FDA Approved: ASMANEX HFA — Supplemental Application (Organon LLC)

View source ↗

Summary

FDA approved a supplemental application for ASMANEX HFA (mometasone furoate) to update the product labeling.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • ASMANEX HFA (mometasone furoate)

Snippet

SUPPL AP for ASMANEX HFA (MOMETASONE FUROATE)